 |
|
Length of Stay and Mortality in Pulmonary EmbolismHigh Time for Evidence-Based Discharge Criteria
Daniel J. Brotman, MD;
Peter K. Lindenauer, MD, MSc
Arch Intern Med. 2008;168(7):683-684.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In 1960, Barritt and Jordan1 published a report of a randomized trial demonstrating the mortality benefit of anticoagulation in the treatment of acute pulmonary embolism (PE).The control arm of the study was terminated when 5 of 19 patients in that arm died of recurrent PE and 5 additional patients experienced recurrent nonfatal PE. Of 54 patients treated with anticoagulants, 1 experienced recurrent nonfatal PE, and 2 died from other causes—1 from bleeding. Patients in both arms stayed in the hospital at least 10 days during mandated bed rest. Only 1 of the 7 deaths occurred within the first week after diagnosis.
With the advent of low-molecular-weight heparins (LMWHs) and increasing pressure to shorten hospital stays, early discharge—or even outpatient treatment from day 1—has become an increasingly common approach to treatment.2 But when we lose the ability to carefully monitor patients—their clinical . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED ARTICLE
Length of Hospital Stay and Postdischarge Mortality in Patients With Pulmonary Embolism: A Statewide Perspective
Drahomir Aujesky, Roslyn A. Stone, Sunghee Kim, Elsa J. Crick, and Michael J. Fine
Arch Intern Med. 2008;168(7):706-712.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Length of Hospital Stay and Mortality in Patients with Pulmonary Embolism
Journal Watch Hospital Medicine 2008;2008:1-1.
FULL TEXT
|
